Navitas Semiconductor Corporation was incorporated in Delaware on August 12, 2020. Founded in 2014, the company is an industry leader in GaN power ICs. Navitas has a strong and growing team of power semiconductor industry experts with 300 years of experience in materials, equipment, applications, systems and marketing, combined with a proven track record of innovation by its founders with over 200 patents. GaN power ICs integrate GaN power with drive, control and protection to enable faster charging, higher power density and greater energy savings for mobile, consumer, enterprise, electric vehicle and new energy markets.
AI Value AnalystSell
Overall Rating3/10
Generated at:2026-06-11 17:41:42
Analysis based on real financial data from 5 quarterly reports: 2026-03-31, 2025-12-31, 2025-09-30, 2025-06-30, and 2025-03-31. Data includes balance sheet, income statement, and key financial ratios. Stock price data as of 2026-06-11 close. Analysis covers financial condition, profitability, and valuation metrics.
Overview
Navitas Semiconductor is a young semiconductor company specializing in GaN and SiC power devices. While it operates in a promising technology niche and maintains a strong, debt-free balance sheet, its fundamental condition is severely challenged by catastrophic operational performance. The company is experiencing severe revenue contraction, accelerating net losses, and deeply negative returns on capital, while its stock trades at an extreme speculative valuation detached from its financial reality.
Valuation
1/10
Profitability
1/10
Financial health
7/10
Operation Advice
Sell the stock.
The current price of $22.21 is massively overvalued relative to fundamental metrics.
Based on a more normalized Price-to-Sales multiple (10x to 25x) for a pre-profit semiconductor company with negative growth, a reasonable fundamental price range is approximately $2.56 to $6.41.
The stock's recent wild price swings (from $9 to over $34 in under 3 months) indicate speculative froth rather than fundamental value.
Avoid this stock until the company demonstrates a clear, sustained path to revenue growth and profitability.
Valuation
P/E TTM
-17.44
P/E LYR
-25.77
P/B MRQ
5.48
P/S TTM
--
AI Analysis
Valuation metrics are extreme and cannot be justified by traditional fundamentals due to the absence of profits and collapsing revenue. The Price-to-Sales ratio of 128.18 is astronomically high, and the current price of $22.21 is massively overvalued relative to the company's financial reality.
Both forward PE (-25.77) and trailing PE (-17.44) are negative, rendering the P/E ratio meaningless as the company has no earnings.
The PB ratio of 5.48 is high, suggesting the market price is valuing intangible assets far above tangible net asset value.
The PS-TTM ratio of 128.18 is astronomically high, implying an extreme premium for future sales growth that contradicts current declining revenue trends.
The current price of $22.21 has been driven by volatile trading and speculation, not fundamentals.
Traditional discounted cash flow or earnings-based models cannot generate a positive intrinsic value given the catastrophic profitability and negative growth profile.
For the current valuation to be reasonable, the company would need to demonstrate immediate, massive, and profitable revenue scaling, which the financials contradict.
A reasonable price range based on a normalized PS multiple (10x to 25x Sales) translates to approximately $2.56 to $6.41 per share.
The current price of $22.21 is massively overvalued relative to its present financial reality.
Valuation trend
Profitability
ROE TTM
-32.49%
Net margin
-392.94%
Gross margin
37.65%
Total revenue
8.60M
AI Analysis
Profitability metrics are deeply negative and worsening. The company is deeply unprofitable with accelerating losses, negative return metrics, and is destroying shareholder value.
The gross margin for Q1 2026 was 37.65%, which is reasonable but fails to translate to operating or net profitability due to high operating expenses.
The net margin was -392.94%, meaning losses are massively outstripping revenue.
Diluted EPS for Q1 2026 was -$0.15, and the annual EPS for 2025 was -$0.57.
The trend shows losses are accelerating on a year-over-year basis (e.g., Q1 2026 Net Income growth: -100.75%).
Return on Equity (ROE-TTM) of -32.49% and Return on Assets (ROA-TTM) of -28.73% are severely negative.
The company is destroying shareholder value and is highly inefficient in generating profits from its asset base.
Profitability
2025Q12025Q22025Q32025Q42026Q1
ROE TTM---17.89%-23.68%-29.55%-32.49%
Earnings
2025Q12025Q22025Q32025Q42026Q1
Total revenue14.02M28.51M38.62M45.92M8.60M
Financial health
Debt/Asset
12.74%
Current ratio
4.33
Quick ratio
4.07
Cash ratio
4.07
AI Analysis
The company shows excellent short-term financial health with strong liquidity and low leverage, but operational performance is deteriorating severely with significant revenue contraction.
The company exhibits excellent short-term financial health with a current ratio of 4.33 and quick ratio of 4.07.
The debt-to-asset ratio of 12.74% is very low, suggesting minimal financial leverage and low insolvency risk.
The balance sheet is not the primary concern.
The critical issue is operational performance, with revenue for Q1 2026 at only $8.60 million.
Revenue represents a severe year-over-year decline of 38.66%.
This continues a consistent pattern of declining revenues visible over the past five reported quarters.
The company is in a significant contraction phase regarding its top-line growth.